Compare · BFLY vs GEHC
BFLY vs GEHC
Side-by-side comparison of Butterfly Network Inc. (BFLY) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $28.76B, about 19.5x BFLY ($1.48B).
- Over the past year, BFLY is up 158.0% and GEHC is down 11.2% - BFLY leads by 169.1 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- GEHC has more recent analyst coverage (25 ratings vs 8 for BFLY).
PerformanceBFLY+157.99%GEHC-11.15%
2025-06-17+0.00%2026-06-16
- Company
- Butterfly Network Inc.
- GE HealthCare Technologies Inc.
- Price
- $5.65+0.36%
- $63.20-2.36%
- Market cap
- $1.48B
- $28.76B
- 1M return
- +47.52%
- +4.03%
- 1Y return
- +157.99%
- -11.15%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 4
- Recent ratings
- 8
- 25
BFLY
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Latest BFLY
- 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
- Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
- Chief Business Officer Cashman Steve sold $1,893,342 worth of shares (399,461 units at $4.74), decreasing direct ownership by 20% to 1,630,407 units (SEC Form 4)
- Deputy General Counsel Caezza Nicholas sold $7,831 worth of shares (1,733 units at $4.52), decreasing direct ownership by 0.56% to 310,307 units (SEC Form 4) to satisfy tax liability
- Director Neubauer Caroll H was granted 73,170 shares (SEC Form 4)
- SEC Form 3 filed by new insider Neubauer Caroll H
- Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
- The Future of Intoxication Detection May Be in Your Voice
Latest GEHC
- GE HealthCare advancing enterprise imaging with cloud-enabled solutions
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
- SEC Form SD filed by GE HealthCare Technologies Inc.
- Director Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)
- GE HealthCare upgraded by UBS with a new price target
- CEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)
- CEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.